Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for HSV Prevention in HSCT Patients
NCT01602562Phase 3Completed
- Sponsor
- GSK
- Start
- May 2012
- Primary completion
- May 2013
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of valaciclovir in herpes simplex virus infection, sponsored by GSK. Primary endpoint: Number of Participants With a Herpes Simplex Virus (HSV) Infection. Started May 2012; status: completed.
02
Drugs
valaciclovir
03
Conditions
herpes simplex virus infection
Beyond the preview
Go deeper on NCT01602562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01602562.